1. Overexpression of cyclin F/CCNF as an independent prognostic factor for poor survival in clear cell renal cell carcinoma
    Maciej Kwiatkowski et al, 2024, Scientific Reports CrossRef
  2. Subgroup-specific prognostic signaling and metabolic pathways in pediatric medulloblastoma
    Ae Kyung Park et al, 2019, BMC Cancer CrossRef
  3. PLK1, A Potential Target for Cancer Therapy
    Zhixian Liu et al, 2017, Translational Oncology CrossRef
  4. Therapeutic Potential of Mitotic Kinases’ Inhibitors in Cancers of the Gastrointestinal System
    Aadil Javed et al, 2022, Future Pharmacology CrossRef
  5. Mitotic Kinase Inhibitors as Therapeutic Interventions for Prostate Cancer: Evidence from In Vitro Studies
    Aadil Javed et al, 2023, Endocrine, Metabolic & Immune Disorders - Drug Targets CrossRef
  6. PLK1 and FoxM1 expressions positively correlate in papillary thyroid carcinoma and their combined inhibition results in synergistic anti‐tumor effects
    Pratheesh Kumar Poyil et al, 2024, Molecular Oncology CrossRef
  7. Impairment of FOXM1 expression in mesenchymal cells from patients with myeloid neoplasms, de novo and therapy-related, may compromise their ability to support hematopoiesis
    Giulia Falconi et al, 2022, Scientific Reports CrossRef
  8. miR-216b inhibits glioma cell migration and invasion through suppression of FoxM1
    Tingting Zhang et al, 2017, Oncology Reports CrossRef
  9. Abnormal expression of FOXM1 in carcinogenesis of renal cell carcinoma: From experimental findings to clinical applications
    Yanmei Shan et al, 2024, Biochemical and Biophysical Research Communications CrossRef
  10. Tanshinone IIA suppresses gastric cancer cell proliferation and migration by downregulation of FOXM1
    Jiao Yu et al, 2017, Oncology Reports CrossRef
  11. Targeting forkhead box M1 transcription factor in breast cancer
    Ruth M. O'Regan et al, 2018, Biochemical Pharmacology CrossRef
  12. FOXK2 suppresses the malignant phenotype and induces apoptosis through inhibition of EGFR in clear‐cell renal cell carcinoma
    Fan Zhang et al, 2018, International Journal of Cancer CrossRef
  13. Tetramethylpyrazine inhibits prostate cancer progression by downregulation of forkhead box M1
    Yi Zhou et al, 2017, Oncology Reports CrossRef
  14. OTUB1-mediated deubiquitination of FOXM1 up-regulates ECT-2 to promote tumor progression in renal cell carcinoma
    Kai Zhou et al, 2020, Cell & Bioscience CrossRef
  15. Polo-like kinase 1 (Plk1) inhibition synergizes with taxanes in triple negative breast cancer
    Antonio Giordano et al, 2019, PLOS ONE CrossRef
  16. FOXM1 and Cancer: Faulty Cellular Signaling Derails Homeostasis
    Dhanya Kalathil et al, 2021, Frontiers in Oncology CrossRef
  17. Transcriptomic and Functional Evidence for Differential Effects of MCF-7 Breast Cancer Cell-Secretome on Vascular and Lymphatic Endothelial Cell Growth
    Giovanna Azzarito et al, 2022, International Journal of Molecular Sciences CrossRef
  18. Multi-omics analysis reveals epithelial-mesenchymal transition-related gene FOXM1 as a novel prognostic biomarker in clear cell renal carcinoma
    Jing Song et al, 2019, Aging CrossRef
  19. LncRNA LOC653786 promotes growth of RCC cells via upregulating FOXM1
    Fan Yang et al, 2018, Oncotarget CrossRef
  20. Sensitization to oxidative stress and G2/M cell cycle arrest by histone deacetylase inhibition in hepatocellular carcinoma cells
    Hae-Ahm Lee et al, 2020, Free Radical Biology and Medicine CrossRef
  21. Co-regulation and function of FOXM1/RHNO1 bidirectional genes in cancer
    Carter J Barger et al, 2021, eLife CrossRef
  22. Long noncoding RNA ENST00000413528 sponges microRNA‐593‐5p to modulate human glioma growth via polo‐like kinase 1
    Ren Zhang et al, 2019, CNS Neuroscience & Therapeutics CrossRef
  23. FOXM1 drives proximal tubule proliferation during repair from acute ischemic kidney injury
    Monica Chang-Panesso et al, 2019, Journal of Clinical Investigation CrossRef
  24. High impact of miRNA-4521 on FOXM1 expression in medulloblastoma
    Daniel Senfter et al, 2019, Cell Death & Disease CrossRef
  25. Dysregulation of miR-23b-5p promotes cell proliferation via targeting FOXM1 in hepatocellular carcinoma
    Xinchen Yang et al, 2021, Cell Death Discovery CrossRef
  26. Exogenous delivery of microRNA-134 (miR-134) using α-tocopherol-based PEGylated liposome for effective treatment in skin squamous cell carcinoma
    Chen Jing et al, 2021, Drug Delivery and Translational Research CrossRef